TY  - JOUR
AU  - Falco, Agustin
AU  - Bueno-de-Oliveira, Thiago 
AU  - Cacicedo, Jon
AU  - Ospina, Aylen Vanessa
AU  - Ticona, Miguel Angel
AU  - Galindo, Hector
AU  - Pereira, Marcos David
AU  - Aguilar-Ponce, Jose Luis
AU  - Rueda-Dominguez, Antonio
AU  - Soria, Tannia
AU  - Taberna, Miren
AU  - Iglesias, Lara
AU  - Sowley, Taysser
AU  - Mesia, Ricard
PY  - 2021
DO  - 10.2147/CMAR.S322411
SN  - 1179-1322
UR  - http://hdl.handle.net/10668/18490
T2  - Cancer management and research
AB  - Cisplatin is the standard of treatment for squamous cell carcinoma of the head and neck (SCCHN) that has demonstrated efficacy, either in locally advanced disease when combined with radiotherapy at high doses, or in metastatic/recurrent disease when...
LA  - en
PB  - Dove Press
KW  - Age
KW  - Cisplatin
KW  - Comorbidities
KW  - Contraindication
KW  - Frailty
KW  - Toxicity
KW  - SARS-CoV-2
KW  - Radiation Oncology
KW  - Squamous Cell Carcinoma of Head and Neck
KW  - Quality of Life
KW  - Pandemics
TI  - Ibero-American Expert Consensus on Squamous Cell Carcinoma of the Head and Neck Treatment in Patients Unable to Receive Cisplatin: Recommendations for Clinical Practice.
TY  - research article
VL  - 13
ER  -